• 1
    Alter MJ. The epidemiology of hepatitis C in the west. Semin Liver Dis 1995; 15: 514.
  • 2
    Alter MJ, Margolis H, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al., for the Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. N Engl J Med 1992; 327: 18991905.
  • 3
    Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 14631466.
  • 4
    Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. HEPATOLOGY 1998; 28: 16871695.
  • 5
    Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825832.
  • 6
    Seeff LB, Hoofnagle JH. The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. HEPATOLOGY 2002; 36( Suppl 1): S1S2.
  • 7
    Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10: 439449.
  • 8
    Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194: 13951406.
  • 9
    Greuner NH, Gerlach TJ, Jung MC, Diepolder HM, Schirren CA, Schraut WW, et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000; 181: 15281536.
  • 10
    Lechner F, Gruener NH, Urbani S, Uggeri J, Santantonio T, Krammer AR, et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000; 30: 24792487.
  • 11
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C infection. HEPATOLOGY 1997; 25: 705712.
  • 12
    Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 14731481.
  • 13
    Rehermann B, Chang KM, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70: 70927102.
  • 14
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, et al. Identification of HLA-A3 and -B7 -restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 1999; 162: 11561164.
  • 15
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 33393344.
  • 16
    Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95: 20672075.
  • 17
    He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A 1999; 96: 56925697.
  • 18
    McKiernan SM, Hagan R, Curry M, McDonald GSA, Nolan N, Crowley J, et al. The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C, derived from a single source. Gastroenterology 2000; 118: 11241130.
  • 19
    Vitte Rl, Fortier C, Richardet JP, Grimbert S, Trinchet JC, Beaugrand M, et al. HLA antigens in patients with chronic hepatitis C. Tissue Antigens 1995; 45: 356361.
  • 20
    Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Sayaka N, et al. Influence of HLA haplotypes on the clinical course of individuals infected with hepatitis C virus. HEPATOLOGY 1998; 27: 240244.
  • 21
    Zavaglia C, Bortolon C, Ferrioli G, Rho A, Mondazzi L, Bottelli R, et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996; 24: 658665.
  • 22
    Miyaguchi S, Saito H, Ebinuma H, Morizane T, Ishii H. Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C. Tissue Antigens 1997; 49: 605611.
  • 23
    Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002; 76: 47924797.
  • 24
    Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340: 12281233.
  • 25
    Irish Government Stationery Office. Report of the expert group on the Blood Transfusion Service Board. ISBN 1995; 07076-1595X.
  • 26
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988: 16: 12151218.
  • 27
    Bunce M, O'Neill CM, Barnardo MCN, Krausa P, Browning MJ, Morris PJ, et al. Photoytping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355367.
  • 28
    Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet 1999; 1: 157176.
  • 29
    Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur J Immunogenet 2001; 28: 565596.
  • 30
    Williams F, Meenagh A, Maxwell AP, Middleton D. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy. Tissue Antigens 1999; 54: 5968.
  • 31
    Middleton D, Williams F, Hamill A, Meenagh A. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy. Hum Immunol 2000; 61: 12851297.
  • 32
    Williams F, Meenagh A, Patterson C, Middleton D. Molecular diversity of the HLA-C gene identified in a Caucasian population. Hum Immunol 2002; 63: 602613.
  • 33
    Greenland S, Rothman KJ. Fundamentals of epidemiologic data analysis. In: RothmanKJ, GreenlandS, eds. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven, 1998: 201230.
  • 34
    Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184: 1621.
  • 35
    Duffy M, Salemi M, Sheehy N, Vandamme A, Hegarty J, Curry M, et al. Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection. Virology 2002; 301: 354364.